Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Tumour and normal tissue radiosensitivity (2022) |
Auteurs : | A. Lapierre ; S. Gourgou ; M. Brengues ; L. Quero ; É. Deutsch ; F. Milliat ; O. Riou ; D. Azria |
Type de document : | Article |
Dans : | Cancer/Radiothérapie (vol. 26, n° 1-2, février-avril 2022) |
Article en page(s) : | p. 96-103 |
Note générale : | https://doi-org.ezproxy.vinci.be/10.1016/j.canrad.2021.11.008 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Radiothérapie ; Recommandations ; Recommandations comme sujet ; Tumeurs |
Mots-clés: | Radiosensibilité ; Tissu sain ; Tests prédictifs |
Résumé : | The place of personalized treatments is highly increasing in medical and radiation oncology. During the last decades, a huge number of assays have been developed to predict responses of normal tissues and tumours. These tests have not yet been included into daily clinical practice but the recent developments of radiation oncology are paving the way of personalized strategies including the risk of tumour recurrence and normal tissue reactions. Concerning tumor radiosensitivity prediction, no test are currently used, even if the radiosensitivity index and the genome-based model for adjusting radiotherapy dose assays seem the most promising with level II of evidence. Commercial developments are under progress. Concerning normal tissue radiosensitivity prediction, single nucleotide polymorphims of prostate cancer patients and radiation-induced CD8 T-lymphocyte apoptosis breast and prostate assays are of level I of evidence. They can be proposed before the beginning of radiotherapy in order to propose personalized treatments according to both risks of tumour and normal tissue radiosensitivity. Commercial developments are also under way. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S1278321821002973 |